EnGeneIC Announces Publication of Preclinical Data Highlightin...
- Written by LATEST ASIANET NEWS RELEASES
- Category: Asia Net
NEW YORK and SYDNEY, March 1, 2018 /PRNewswire-AsiaNet/ -- EnGeneIC Limited (http://www.engeneic.com/ ), a clinical stage biopharmaceutical company focused on developing its proprietary EDV(TM) nanocell platform for targeted cyto-immunotherapy in cancer, today announced the publication of preclinical find......




